Search Results - Jesse J. Swen

Refine Results
  1. 1
    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands

    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands by Paul CD Bank, Jesse J. Swen, Henk‐Jan Guchelaar

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements

    Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements by Rawan Shekhani, Linda Steinacher, Jesse J. Swen, Magnus Ingelman‐Sundberg

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines by Lisanne E. N. Manson, Jesse J. Swen, Henk‐Jan Guchelaar

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review by Sylvia D. Klomp, Martijn L. Manson, Henk‐Jan Guchelaar, Jesse J. Swen

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Technologies for Pharmacogenomics: A Review

    Technologies for Pharmacogenomics: A Review by Maaike van der Lee, Marjolein Kriek, Henk‐Jan Guchelaar, Jesse J. Swen

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics

    Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics by Laura M. de Jong, Wim Jiskoot, Jesse J. Swen, Martijn L. Manson

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice by Alireza Tafazoli, Henk‐Jan Guchelaar, Wojciech Miltyk, Adam Krętowski, Jesse J. Swen

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation pr... by Katja S. Just, Michael Steffens, Jesse J. Swen, George P. Patrinos, Henk‐Jan Guchelaar, Julia Stingl

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact

    Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact by Cathelijne H. van der Wouden, Paul C. D. Bank, Kübra Özokcu, Jesse J. Swen, Henk‐Jan Guchelaar

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients

    The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients by Teun van Gelder, Soufian Meziyerh, Jesse J. Swen, Aiko P. J. de Vries, Dirk Jan A. R. Moes

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Translating Pharmacogenomics: Challenges on the Road to the Clinic

    Translating Pharmacogenomics: Challenges on the Road to the Clinic by Jesse J. Swen, T. Huizinga, Hans Gelderblom, Elisabeth G.E. de Vries, Willem JJ Assendelft, Julia Kirchheiner, Henk‐Jan Guchelaar

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen

    Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen by Anabel Sanchez‐Spitman, Jesse J. Swen, Vincent O. Dezentjé, Dirk Jan A. R. Moes, Hans Gelderblom, Henk‐Jan Guchelaar

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care

    A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care by Paul C. D. Bank, Jesse J. Swen, Rowena D. Schaap, Daniëlle B. Klootwijk, Renée Baak – Pablo, Henk‐Jan Guchelaar

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism

    Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism by A. B. Sanchez Spitman, Dirk Jan A. R. Moes, Hans Gelderblom, Vincent O. Dezentjé, Jesse J. Swen, Henk‐Jan Guchelaar

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing

    Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing by Kelly E. Caudle, Caroline F. Thorn, Teri E. Klein, Jesse J. Swen, Howard L. McLeod, Robert B. Diasio, Matthias Schwab

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Translating <i>DPYD</i> Genotype into DPD Phenotype: Using the <i>DPYD</i> Gene Activity Score

    Translating <i>DPYD</i> Genotype into DPD Phenotype: Using the <i>DPYD</i> Gene Activity Score by Linda M. Henricks, Carin ATC Lunenburg, Didier Meulendijks, Hans Gelderblom, Annemieke Cats, Jesse J. Swen, Jan H.M. Schellens, Henk‐Jan Guchelaar

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time

    Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time by Carin A.T.C. Lunenburg, Linda M. Henricks, Henk‐Jan Guchelaar, Jesse J. Swen, Maarten J. Deenen, Jan H.M. Schellens, Hans Gelderblom

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Pharmacogenomic testing in paediatrics: Clinical implementation strategies

    Pharmacogenomic testing in paediatrics: Clinical implementation strategies by Charlotte Barker, Gabriella Groeneweg, Anke H. Maitland‐van der Zee, Michael Rieder, Daniel B. Hawcutt, Tim Hubbard, Jesse J. Swen, Bruce Carleton

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients

    Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients by Thomas Vanhove, Hanneke Bouwsma, Luuk B. Hilbrands, Jesse J. Swen, Isabel Spriet, Pieter Annaert, Bart M. Vanaudenaerde, Geert M. Verleden, Robin Vos, Dirk Kuypers

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

    Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants by J. Kevin Hicks, Jesse J. Swen, Caroline F. Thorn, Katrin Sangkuhl, E D Kharasch, V L Ellingrod, Todd C. Skaar, D Müller, Andrea Gaedigk, Julia Stingl

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: